Radiographic patterns of relapse in glioblastoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-01

AUTHORS

Marc C. Chamberlain

ABSTRACT

Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab. More... »

PAGES

319-323

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4

DOI

http://dx.doi.org/10.1007/s11060-010-0251-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011002727

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21052776


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Washington", 
          "id": "https://www.grid.ac/institutes/grid.34477.33", 
          "name": [
            "Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Research Cancer Center, University of Washington, 895 Eastlake Ave, POB Box 19023, MS-G4-940, 98109-1023, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2007.12.2440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008387745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.3055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010751135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2009-006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011570339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.10.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038799886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.8721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042965400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00146880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046803627", 
          "https://doi.org/10.1007/bf00146880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00146880", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046803627", 
          "https://doi.org/10.1007/bf00146880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181bc0184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354676"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-01", 
    "datePublishedReg": "2011-01-01", 
    "description": "Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-010-0251-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "101"
      }
    ], 
    "name": "Radiographic patterns of relapse in glioblastoma", 
    "pagination": "319-323", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "346bf36d52242c9a96adb1e218e0334c6e1fa029b1ed987181faf064c873146b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21052776"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-010-0251-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011002727"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-010-0251-4", 
      "https://app.dimensions.ai/details/publication/pub.1011002727"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113670_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-010-0251-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0251-4'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      21 PREDICATES      60 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-010-0251-4 schema:about N3198f69a635c406382869b2d5d8a51a0
2 N31a7650f1d4b4d5797bc2449c3a2ffac
3 N45a2e73ecdb74aa4a578478500a22147
4 N69c82665cffd4f788424ffc9d0267531
5 N6a4d8fd2475a40b6a58c28f7ed89d238
6 N71f08af6728549b1a9a428c48a80f124
7 N7c6fc7a3afcc49ca9a96b741c3f1e37c
8 N966e0c97957a441fbcb00c51c4aa41c0
9 N974b5e8b1e874d6690f4d91c555a04e1
10 Na1d933a6acfc4e05aee05219a9b55e94
11 Nb69627db787649a9bb50cb9c9e0834ae
12 Nbb381bdc0c774cec85ef7bd6511050b8
13 Nbda55d6b1d79474d9419471d9b7bbcef
14 Nc91fcd62572147d9820cc3f344e5669b
15 Ne07771b0194b4ed3831c877220f7519f
16 Ne73057c6a6d649149eedfd876226d85b
17 Ne7f4f7a5e6b340b794f0331e1f56587e
18 Ne9626b945bcf40d6a541f8641b14e447
19 Nf1e7cf4ffaa04b78bfac07fb368a8b07
20 Nfb3db6c715b54069a83ba43f059b8771
21 Nfc7b339bea554977b7b27acdfe3dceff
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N7219ed429919457dbbaf52dcdf28a3e8
25 schema:citation sg:pub.10.1007/bf00146880
26 https://doi.org/10.1016/j.ijrobp.2008.10.043
27 https://doi.org/10.1056/nejmoa043330
28 https://doi.org/10.1200/jco.2007.12.2440
29 https://doi.org/10.1200/jco.2008.16.3055
30 https://doi.org/10.1200/jco.2008.19.8721
31 https://doi.org/10.1200/jco.2009.26.3541
32 https://doi.org/10.1212/01.wnl.0000304121.57857.38
33 https://doi.org/10.1212/wnl.0b013e3181bc0184
34 https://doi.org/10.1215/15228517-2009-006
35 schema:datePublished 2011-01
36 schema:datePublishedReg 2011-01-01
37 schema:description Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree false
41 schema:isPartOf N187844bbcdfb428daca84e959dae2032
42 N2e28a53b8c3946eaae3679967fbfb199
43 sg:journal.1094205
44 schema:name Radiographic patterns of relapse in glioblastoma
45 schema:pagination 319-323
46 schema:productId N13120249e04840a3892f2ed9f2f2bb68
47 N37ef34a8fd5b4ad7aa0fad9116d6d29b
48 N38868b08984e4cfa87791a4c0813e117
49 N5258edbce5c94358b7228f072c40f581
50 Ne9df7f9ea76d4812b8aa0b1eb83542c7
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011002727
52 https://doi.org/10.1007/s11060-010-0251-4
53 schema:sdDatePublished 2019-04-11T10:35
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N3175cc3e8b9b4c5f99853646695667db
56 schema:url http://link.springer.com/10.1007%2Fs11060-010-0251-4
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N13120249e04840a3892f2ed9f2f2bb68 schema:name doi
61 schema:value 10.1007/s11060-010-0251-4
62 rdf:type schema:PropertyValue
63 N187844bbcdfb428daca84e959dae2032 schema:volumeNumber 101
64 rdf:type schema:PublicationVolume
65 N2e28a53b8c3946eaae3679967fbfb199 schema:issueNumber 2
66 rdf:type schema:PublicationIssue
67 N3175cc3e8b9b4c5f99853646695667db schema:name Springer Nature - SN SciGraph project
68 rdf:type schema:Organization
69 N3198f69a635c406382869b2d5d8a51a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Middle Aged
71 rdf:type schema:DefinedTerm
72 N31a7650f1d4b4d5797bc2449c3a2ffac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Treatment Outcome
74 rdf:type schema:DefinedTerm
75 N37ef34a8fd5b4ad7aa0fad9116d6d29b schema:name pubmed_id
76 schema:value 21052776
77 rdf:type schema:PropertyValue
78 N38868b08984e4cfa87791a4c0813e117 schema:name dimensions_id
79 schema:value pub.1011002727
80 rdf:type schema:PropertyValue
81 N45a2e73ecdb74aa4a578478500a22147 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Brain Neoplasms
83 rdf:type schema:DefinedTerm
84 N5258edbce5c94358b7228f072c40f581 schema:name readcube_id
85 schema:value 346bf36d52242c9a96adb1e218e0334c6e1fa029b1ed987181faf064c873146b
86 rdf:type schema:PropertyValue
87 N69c82665cffd4f788424ffc9d0267531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Young Adult
89 rdf:type schema:DefinedTerm
90 N6a4d8fd2475a40b6a58c28f7ed89d238 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Radiography
92 rdf:type schema:DefinedTerm
93 N71f08af6728549b1a9a428c48a80f124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Aged
95 rdf:type schema:DefinedTerm
96 N7219ed429919457dbbaf52dcdf28a3e8 rdf:first sg:person.01326261166.36
97 rdf:rest rdf:nil
98 N7c6fc7a3afcc49ca9a96b741c3f1e37c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Temozolomide
100 rdf:type schema:DefinedTerm
101 N966e0c97957a441fbcb00c51c4aa41c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Combined Modality Therapy
103 rdf:type schema:DefinedTerm
104 N974b5e8b1e874d6690f4d91c555a04e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Glioblastoma
106 rdf:type schema:DefinedTerm
107 Na1d933a6acfc4e05aee05219a9b55e94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Antineoplastic Agents, Alkylating
109 rdf:type schema:DefinedTerm
110 Nb69627db787649a9bb50cb9c9e0834ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Dacarbazine
112 rdf:type schema:DefinedTerm
113 Nbb381bdc0c774cec85ef7bd6511050b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Time Factors
115 rdf:type schema:DefinedTerm
116 Nbda55d6b1d79474d9419471d9b7bbcef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Antineoplastic Agents
118 rdf:type schema:DefinedTerm
119 Nc91fcd62572147d9820cc3f344e5669b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Adult
121 rdf:type schema:DefinedTerm
122 Ne07771b0194b4ed3831c877220f7519f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Male
124 rdf:type schema:DefinedTerm
125 Ne73057c6a6d649149eedfd876226d85b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 Ne7f4f7a5e6b340b794f0331e1f56587e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Neoplasm Recurrence, Local
130 rdf:type schema:DefinedTerm
131 Ne9626b945bcf40d6a541f8641b14e447 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Magnetic Resonance Imaging
133 rdf:type schema:DefinedTerm
134 Ne9df7f9ea76d4812b8aa0b1eb83542c7 schema:name nlm_unique_id
135 schema:value 8309335
136 rdf:type schema:PropertyValue
137 Nf1e7cf4ffaa04b78bfac07fb368a8b07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Female
139 rdf:type schema:DefinedTerm
140 Nfb3db6c715b54069a83ba43f059b8771 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Retrospective Studies
142 rdf:type schema:DefinedTerm
143 Nfc7b339bea554977b7b27acdfe3dceff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Salvage Therapy
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
150 schema:name Oncology and Carcinogenesis
151 rdf:type schema:DefinedTerm
152 sg:journal.1094205 schema:issn 0167-594X
153 1573-7373
154 schema:name Journal of Neuro-Oncology
155 rdf:type schema:Periodical
156 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.34477.33
157 schema:familyName Chamberlain
158 schema:givenName Marc C.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
160 rdf:type schema:Person
161 sg:pub.10.1007/bf00146880 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046803627
162 https://doi.org/10.1007/bf00146880
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.ijrobp.2008.10.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038799886
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1200/jco.2007.12.2440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008387745
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1200/jco.2008.16.3055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010751135
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1200/jco.2008.19.8721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042965400
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1200/jco.2009.26.3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187529
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1212/01.wnl.0000304121.57857.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064350042
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1212/wnl.0b013e3181bc0184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354676
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1215/15228517-2009-006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011570339
181 rdf:type schema:CreativeWork
182 https://www.grid.ac/institutes/grid.34477.33 schema:alternateName University of Washington
183 schema:name Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Research Cancer Center, University of Washington, 895 Eastlake Ave, POB Box 19023, MS-G4-940, 98109-1023, Seattle, WA, USA
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...